Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03790878 · ClinicalTrials.gov registry record · NA

Emotion Regulation and Emotion Perception

A NA study of Emotions, sponsored by Duke University.

Completed
Registry status
NA
Development phase
91
Enrollment target
1
Study location

NCT03790878: Completed NA study of Emotions, sponsored by Duke University.

NCT03790878 is a NA study of Emotions that has completed, run by Duke University. The registered enrollment target is 91 participants, below the 182-participant average among 16 other Emotions trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03790878, a NA study of Emotions, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
91 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the impact of a brief, emotion regulation intervention on the ability to perceive other people's emotions.

Primary Outcome

Emotion perception is measured by a computer-based behavioral assessment during the laboratory session. Scores for negative emotional expressions range from 0-100%, with higher scores indicating greater emotion perception accuracy.

Conditions Studied

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Mindful Breathing
  • BEHAVIORAL Habituation

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 91 participants
Start Date 2019-02-04
Est. Completion 2019-12-02
Phase NA
Duke University

1,725 total trials

What the finished NCT03790878 record still lists

NCT03790878 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 182-participant average among 16 other Emotions trials with a reported enrollment target (50% lower).

The record links to 1 condition, with Emotions appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.

NCT03790878 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT03790878 about?

NCT03790878 is a clinical study titled "Emotion Regulation and Emotion Perception". The purpose of this study is to assess the impact of a brief, emotion regulation intervention on the ability to perceive other people's emotions.

What is the current status of trial NCT03790878?

This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2019-02-04. Estimated completion is 2019-12-02.

What conditions does trial NCT03790878 study?

This clinical trial studies the following conditions: Emotions.

What interventions are being tested in trial NCT03790878?

The interventions under investigation include: Control (BEHAVIORAL), Mindful Breathing (BEHAVIORAL), Habituation (BEHAVIORAL).

Who is sponsoring clinical trial NCT03790878?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03790878 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Emotions

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03790878's enrollment target sits among peer trials

91 11th of 16 higher than 6 of 16 other Emotions trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Emotions trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02671448 · 91 participants · NA

    Pilot Trial of Homebound Stem Cell Transplantation

  • NCT04835857 · 91 participants

    Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices

  • NCT05184842 · 91 participants · Phase 2

    Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML

  • NCT05685173 · 91 participants · Phase 1

    A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03790878, the US trial registry maintained by the National Library of Medicine. NCT03790878 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.